$CNS
COHEN & STEERS, INC.

2021 Q1 Form 10-Q Financial Statement

#000128481221000175 Filed on May 07, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $125.7M $105.8M
YoY Change 18.82% 12.32%
Cost Of Revenue $16.50M $14.10M
YoY Change 17.02% 12.8%
Gross Profit $109.2M $91.70M
YoY Change 19.08% 12.24%
Gross Profit Margin 86.84% 86.65%
Selling, General & Admin $56.10M $62.20M
YoY Change -9.81% 37.61%
% of Gross Profit 51.37% 67.83%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.167M $1.200M
YoY Change -2.75% 9.09%
% of Gross Profit 1.07% 1.31%
Operating Expenses $73.81M $77.46M
YoY Change -4.71% 31.76%
Operating Profit $51.94M $28.37M
YoY Change 83.08% -19.94%
Interest Expense $5.200M -$20.90M
YoY Change -124.88% -235.71%
% of Operating Profit 10.01% -73.67%
Other Income/Expense, Net $4.953M -$19.84M
YoY Change -124.96% -233.09%
Pretax Income $56.89M $8.526M
YoY Change 567.26% -83.06%
Income Tax $4.461M $458.0K
% Of Pretax Income 7.84% 5.37%
Net Earnings $48.85M $20.57M
YoY Change 137.47% -36.79%
Net Earnings / Revenue 38.85% 19.44%
Basic Earnings Per Share $1.01 $0.43
Diluted Earnings Per Share $1.00 $0.42
COMMON SHARES
Basic Shares Outstanding 48.15M shares 47.65M shares
Diluted Shares Outstanding 48.71M shares 48.59M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $54.70M $43.00M
YoY Change 27.21% -23.76%
Cash & Equivalents $54.72M $42.96M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $72.00M $63.70M
Other Receivables $0.00 $0.00
Total Short-Term Assets $126.7M $106.7M
YoY Change 18.74% -8.33%
LONG-TERM ASSETS
Property, Plant & Equipment $9.604M $12.09M
YoY Change -20.57% -13.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $15.00K $407.0K
YoY Change -96.31% 1669.57%
Other Assets $2.100M $6.800M
YoY Change -69.12% -4.23%
Total Long-Term Assets $206.4M $227.0M
YoY Change -9.06% -21.58%
TOTAL ASSETS
Total Short-Term Assets $126.7M $106.7M
Total Long-Term Assets $206.4M $227.0M
Total Assets $333.1M $333.7M
YoY Change -0.17% -17.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $100.0K $100.0K
YoY Change 0.0% -90.0%
Accrued Expenses $51.70M $53.40M
YoY Change -3.18% -15.1%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $71.40M $82.70M
YoY Change -13.66% -15.7%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $10.10M $13.90M
YoY Change -27.34% 71.6%
Total Long-Term Liabilities $10.10M $13.90M
YoY Change -27.34% 71.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $71.40M $82.70M
Total Long-Term Liabilities $10.10M $13.90M
Total Liabilities $81.50M $96.55M
YoY Change -15.59% -9.17%
SHAREHOLDERS EQUITY
Retained Earnings -$265.0M -$240.9M
YoY Change 10.0% 24.5%
Common Stock $542.0K $535.0K
YoY Change 1.31% 1.9%
Preferred Stock
YoY Change
Treasury Stock (at cost) $222.0M $200.7M
YoY Change 10.64% 14.82%
Treasury Stock Shares 5.983M shares 5.673M shares
Shareholders Equity $189.2M $195.5M
YoY Change
Total Liabilities & Shareholders Equity $333.1M $333.7M
YoY Change -0.17% -17.78%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $48.85M $20.57M
YoY Change 137.47% -36.79%
Depreciation, Depletion And Amortization $1.167M $1.200M
YoY Change -2.75% 9.09%
Cash From Operating Activities $8.913M -$5.553M
YoY Change -260.51% -81.18%
INVESTING ACTIVITIES
Capital Expenditures $431.0K $843.0K
YoY Change -48.87% -14.76%
Acquisitions
YoY Change
Other Investing Activities $39.60M -$7.200M
YoY Change -650.0% -174.23%
Cash From Investing Activities $39.20M -$8.012M
YoY Change -589.27% -191.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $20.89M $25.59M
YoY Change -18.36% 153.87%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$34.50M -$43.55M
YoY Change -20.79% 169.45%
NET CHANGE
Cash From Operating Activities $8.913M -$5.553M
Cash From Investing Activities $39.20M -$8.012M
Cash From Financing Activities -$34.50M -$43.55M
Net Change In Cash $13.62M -$57.11M
YoY Change -123.84% 54.67%
FREE CASH FLOW
Cash From Operating Activities $8.913M -$5.553M
Capital Expenditures $431.0K $843.0K
Free Cash Flow $8.482M -$6.396M
YoY Change -232.61% -79.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001284812
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10017
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-32236
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
COHEN & STEERS, INC.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
14-1904657
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
280 Park Avenue
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021Q1 dei City Area Code
CityAreaCode
212
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
832-3232
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2021Q1 dei Trading Symbol
TradingSymbol
CNS
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48240669 shares
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54717000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41232000 USD
CY2021Q1 us-gaap Investments
Investments
128437000 USD
CY2020Q4 us-gaap Investments
Investments
154978000 USD
CY2021Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
71957000 USD
CY2020Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
69680000 USD
CY2021Q1 us-gaap Due From Correspondent Brokers
DueFromCorrespondentBrokers
6081000 USD
CY2020Q4 us-gaap Due From Correspondent Brokers
DueFromCorrespondentBrokers
5125000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9604000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10341000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10341000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10341000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10341000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28646000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
31203000 USD
CY2021Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
20048000 USD
CY2020Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
20495000 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2065000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6995000 USD
CY2021Q1 us-gaap Other Assets
OtherAssets
11538000 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
8404000 USD
CY2021Q1 us-gaap Assets
Assets
333093000 USD
CY2020Q4 us-gaap Assets
Assets
348453000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
19660000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
52056000 USD
CY2021Q1 cns Distribution And Service Fees Payable
DistributionAndServiceFeesPayable
8598000 USD
CY2020Q4 cns Distribution And Service Fees Payable
DistributionAndServiceFeesPayable
7748000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
32068000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
34926000 USD
CY2021Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
10991000 USD
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
12672000 USD
CY2021Q1 srt Payables To Broker Dealers And Clearing Organizations
PayablesToBrokerDealersAndClearingOrganizations
134000 USD
CY2020Q4 srt Payables To Broker Dealers And Clearing Organizations
PayablesToBrokerDealersAndClearingOrganizations
501000 USD
CY2021Q1 us-gaap Other Liabilities
OtherLiabilities
10050000 USD
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
15646000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
81501000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
123549000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Redeemable Noncontrolling Interest Equity Common Fair Value
RedeemableNoncontrollingInterestEquityCommonFairValue
62365000 USD
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Common Fair Value
RedeemableNoncontrollingInterestEquityCommonFairValue
50665000 USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
535000 USD
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54220098 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53462621 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
542000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
680466000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
670142000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-265034000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-291542000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4729000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4134000 USD
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
5983474 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5674510 shares
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
222018000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
200762000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
189227000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
174239000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
333093000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
348453000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
125747000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
105830000 USD
CY2021Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
45762000 USD
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
38617000 USD
CY2021Q1 us-gaap Sponsor Fees
SponsorFees
16506000 USD
CY2020Q1 us-gaap Sponsor Fees
SponsorFees
14104000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10374000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23588000 USD
CY2021Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1167000 USD
CY2020Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1152000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
73809000 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
77461000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
51938000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
28369000 USD
CY2021Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
616000 USD
CY2020Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1149000 USD
CY2021Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
4559000 USD
CY2020Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-22027000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-222000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1035000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4953000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19843000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
56891000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8526000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4461000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
458000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
52430000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
8068000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3578000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-12504000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
48852000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
20572000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.01
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.00
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.39
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48145000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47651000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48709000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48591000 shares
CY2021Q1 us-gaap Profit Loss
ProfitLoss
52430000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
8068000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3578000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-12504000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
48852000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
20572000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-595000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1500000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
48257000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
19072000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
174239000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2021Q1 us-gaap Dividends
Dividends
22344000 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
430000 USD
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
21256000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
793000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9185000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
77000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
48852000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-595000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
189227000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
213703000 USD
CY2020Q1 us-gaap Dividends
Dividends
19041000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
305000 USD
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
25847000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
553000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6775000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
16000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
20572000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1500000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
195504000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
52430000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
8068000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
9348000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6970000 USD
CY2021Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
347000 USD
CY2020Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
443000 USD
CY2021Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1167000 USD
CY2020Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1152000 USD
CY2021Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2557000 USD
CY2020Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2479000 USD
CY2021Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-17000 USD
CY2020Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
84000 USD
CY2021Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
4559000 USD
CY2020Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-22027000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4919000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
281000 USD
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1059000 USD
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-158000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3336000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4716000 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
358000 USD
CY2021Q1 us-gaap Increase Decrease In Brokerage Receivables
IncreaseDecreaseInBrokerageReceivables
956000 USD
CY2020Q1 us-gaap Increase Decrease In Brokerage Receivables
IncreaseDecreaseInBrokerageReceivables
-1598000 USD
CY2020Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
440000 USD
CY2021Q1 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
8695000 USD
CY2020Q1 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
2011000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2978000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2343000 USD
CY2021Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-32396000 USD
CY2020Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-35309000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
850000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-1289000 USD
CY2021Q1 cns Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
-2858000 USD
CY2020Q1 cns Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
-2762000 USD
CY2021Q1 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
-367000 USD
CY2020Q1 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
-284000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1684000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
968000 USD
CY2021Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-5594000 USD
CY2020Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-459000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8913000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5553000 USD
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
17417000 USD
CY2020Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
9634000 USD
CY2021Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
57048000 USD
CY2020Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
2392000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
431000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
843000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2020Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
73000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
39200000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8012000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
365000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
259000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
21256000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25847000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
21726000 USD
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
18653000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
733000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
1946000 USD
CY2021Q1 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
8855000 USD
CY2020Q1 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
2639000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-34495000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-43548000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13618000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-57113000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-133000 USD
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1279000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41232000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
101352000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54717000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42960000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1226000 USD
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1784000 USD
CY2020Q1 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
2517000 USD
CY2021Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
618000 USD
CY2020Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
388000 USD
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">—The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities at the dates of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes the estimates used in preparing the condensed consolidated financial statements are reasonable and prudent. Actual results could differ from those estimates.</span>
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
125747000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
105830000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
125747000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
105830000 USD
CY2021Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
100486000 USD
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
94089000 USD
CY2021Q1 us-gaap Trading Securities Debt
TradingSecuritiesDebt
27936000 USD
CY2020Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
18700000 USD
CY2021Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
0 USD
CY2020Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
41648000 USD
CY2021Q1 us-gaap Equity Method Investments
EquityMethodInvestments
15000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
541000 USD
CY2021Q1 us-gaap Investments
Investments
128437000 USD
CY2020Q4 us-gaap Investments
Investments
154978000 USD
CY2020Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
41700000 USD
CY2021Q1 cns Debt Securities Held To Maturity Number Of Securities Matured
DebtSecuritiesHeldToMaturityNumberOfSecuritiesMatured
2 security
CY2021Q1 cns Debt Securities Held To Maturity Matured In The Period
DebtSecuritiesHeldToMaturityMaturedInThePeriod
25000000.0 USD
CY2021Q1 cns Debt Securities Held To Maturity Number Of Securities Sold
DebtSecuritiesHeldToMaturityNumberOfSecuritiesSold
2 security
CY2021Q1 us-gaap Debt Securities Held To Maturity Sold Amount
DebtSecuritiesHeldToMaturitySoldAmount
16700000 USD
CY2020Q1 cns Number Of New Funds Seeded
NumberOfNewFundsSeeded
0 new_funds_seeded
CY2021Q1 cns Number Of New Funds Seeded
NumberOfNewFundsSeeded
0 new_funds_seeded
CY2021Q1 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
1889000 USD
CY2020Q1 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
-1230000 USD
CY2021Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
2670000 USD
CY2020Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-20797000 USD
CY2021Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
4559000 USD
CY2020Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-22027000 USD
CY2021Q1 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
21354000 USD
CY2021Q1 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
50191000 USD
CY2021Q1 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
1731000 USD
CY2021Q1 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
1930000 USD
CY2020Q4 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
13624000 USD
CY2020Q4 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
45604000 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
1012000 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
2459000 USD
CY2021Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-8000 USD
CY2020Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
137000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
52430000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
8068000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3578000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-12504000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
48852000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
20572000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48145000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47651000 shares
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
564000 shares
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
940000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48709000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48591000 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.01
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.00
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210

Files In Submission

Name View Source Status
0001284812-21-000175-index-headers.html Edgar Link pending
0001284812-21-000175-index.html Edgar Link pending
0001284812-21-000175.txt Edgar Link pending
0001284812-21-000175-xbrl.zip Edgar Link pending
cns-20210331.htm Edgar Link pending
cns-20210331.xsd Edgar Link pending
cns-20210331_cal.xml Edgar Link unprocessable
cns-20210331_def.xml Edgar Link unprocessable
cns-20210331_g1.jpg Edgar Link pending
cns-20210331_htm.xml Edgar Link completed
cns-20210331_lab.xml Edgar Link unprocessable
cns-20210331_pre.xml Edgar Link unprocessable
cns10q-33121ex311.htm Edgar Link pending
cns10q-33121ex312.htm Edgar Link pending
cns10q-33121ex321.htm Edgar Link pending
cns10q-33121ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending